Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - cefpodoxime (proxetil) 50 mg/5ml - 50 mg/5ml

Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - cefpodoxime (proxetil) 100 mg - 100 mg

Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - cefpodoxime (proxetil) 200 mg - 200 mg

Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - cefpodoxime (proxetil) 200 mg - 200 mg

Ιορδανία - Αγγλικά - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - cefpodoxime (proxetil) 200 mg - 200 mg

Ισραήλ - Αγγλικά - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - magnesium chloride 0.1017 g; calcium chloride 0.1838 g; glucose as monohydrate 16.5 g; lactic acid as sodium 3.925 g; sodium chloride 5.786 g - combinations - combinations - for use in patients with end-stage (decompensated)chronic renal failure of any origin which can be treated with peritoneal dealysis.17/10/2017 בקשה לשינוי משטר מינוןשינוי משטר מינון בהתאם למאושר באירופה

Ισραήλ - Αγγλικά - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.786 g; lactic acid as sodium 3.925 g; glucose as monohydrate 46.75 g; calcium chloride 0.1838 g; magnesium chloride 0.1017 g - combinations - combinations - for use in patients with end-stage (decompensated )chronic renal failure of any origin which can be treated with peritoneal dealysis.17/10/2017 בקשה לשינוי משטר מינוןשינוי משטר מינון בהתאם למאושר באירופה

Ισραήλ - Αγγλικά - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - magnesium chloride 0.1017 g; glucose as monohydrate 25 g; calcium chloride 0.1838 g; sodium chloride 5.786 g; lactic acid as sodium 3.925 g - combinations - combinations - for use in patients with end-stage (decompensated )chronic renal failure of any origin which can be treated with peritoneal dealysis.17/10/2017 בקשה לשינוי משטר מינוןשינוי משטר מינון בהתאם למאושר באירופה

Ισραήλ - Αγγλικά - Ministry of Health

abbott medical laboratories ltd, israel - dydrogesterone; estradiol as hemihydrate - film coated tablets - dydrogesterone 2.5 mg; estradiol as hemihydrate 0.5 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.femoston is indicated for women with an intact uterus

Ισραήλ - Αγγλικά - Ministry of Health

abbott medical laboratories ltd, israel - dydrogesterone; estradiol as hemihydrate - film coated tablets - dydrogesterone 5 mg; estradiol as hemihydrate 1 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.prevention of osteoporosis in postmenopausal women at high risk of future fractures. femoston contini 1/5 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.femoston is indicated for women with an intact uterus